Skip to main content

Greenbrook Tms Inc TSX: GTMS-T

Today's Change
Volume
Real-Time Last Update TSX Last Sale

Today's Trading

Day Low 8.90
Day High 9.00
Open:9.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 510,000 TMS treatments to over 14,000 patients struggling with depression. The company has one reportable segment such as outpatient mental health service centers.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

No rating

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Latest Press Releases

Greenbrook TMS Announces Closing of Achieve TMS East and Central Acquisition
- Business Wire - Fri Oct 1, 8:07AM CDT
Business Wire - CMTX
Fri Oct 1, 8:07AM CDT
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, is pleased to announce the closing of the acquisition of Achieve TMS East, LLC ("Achieve TMS East") and Achieve TMS Central, LLC ("Achieve TMS Central", and together with Achieve TMS East, "Achieve TMS East/Central").
Greenbrook TMS Completes US$13.2 Million Bought Deal Public Offering
- Business Wire - Mon Sep 27, 7:47AM CDT
Business Wire - CMTX
Mon Sep 27, 7:47AM CDT
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, is pleased to announce the closing of its previously-announced public offering (the "Offering"). The Offering was made pursuant to an underwriting agreement entered into among Stifel GMP, Bloom Burton Securities Inc. and Lake Street Capital Markets, LLC (collectively, the "Underwriters").
Greenbrook TMS Announces Increase to Bought Deal Financing to US$11.5 Million
- Business Wire - Wed Sep 22, 9:54AM CDT
Business Wire - CMTX
Wed Sep 22, 9:54AM CDT
Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, is pleased to announce that, due to strong demand, the Company has agreed with a syndicate of underwriters co-led by Stifel GMP and Bloom Burton Securities Inc. (collectively, the "Underwriters"), to increase the size of its previously announced US$10,075,000 (or C$12,909,000) bought deal offering. Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a "bought deal" basis, 1,485,000 common shares of the Company (the "Common Shares") at a price of US$7.75 (or C$9.93) per Common Share (the "Offering Price"), for aggregate gross proceeds of US$11,508,750 (or C$14,746,050) (the "Offering").
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 8.69 +2.42% increase
on 10/15/21
Period Open:11.27
Price movement based on the high, low and last over the given period.
12.30 -27.64% decrease
on 09/21/21
-2.37 (-21.03%) decrease
since 09/17/21
3-Month 8.69 +2.42% increase
on 10/15/21
Period Open:15.14
Price movement based on the high, low and last over the given period.
15.30 -41.83% decrease
on 07/22/21
-6.24 (-41.22%) decrease
since 07/16/21
52-Week 6.65 +33.83% increase
on 11/06/20
Period Open:7.50
Price movement based on the high, low and last over the given period.
22.40 -60.27% decrease
on 02/02/21
+1.40 (+18.67%) increase
since 10/16/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies